Position history for BlackRock, Inc.'s holdings in ARS PHARMACEUTICALS INC
BlackRock, Inc. holds 5.1M shares of SPRY (ARS PHARMACEUTICALS INC), worth $59.2M as of 2025-Q4. The position was increased (++5.3% shares). SPRY represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$59.2M
Current Shares
5.1M
Total Value Change
+$11M
Total Shares Change
+510,826
Other major holders of SPRY: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, RA CAPITAL MANAGEMENT, L.P.
Increased |
| 5.1M |
+5.3% |
| $59.2M |
| 0.0% |
| $11.64 |
31 |
| 2025-Q3 | Increased | 4.8M | +9.2% | $48.6M | 0.0% | $9.72 | 32 |
| 2025-Q2 | Increased | 4.4M | +2.9% | $77.2M | 0.0% | $18.20 | 31 |
| 2025-Q1 | Decreased | 4.3M | -6.0% | $54.1M | 0.0% | $12.49 | 0 |
| 2024-Q4 | New | 4.6M | - | $48.3M | 0.0% | $10.62 | 40 |